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Abstract 
Regulatory cooperation is both one of the most ambitious and contentious parts of the EU-US 
Transatlantic Trade and Investment Partnership (TTIP) negotiations. In this paper, having 
identified the many levels of international regulatory cooperation, we show that TTIP 
regulatory cooperation will be significant, but not ambitious, while political and legal limits 
on cooperation in both the EU and the US minimise the concerns. For transatlantic regulatory 
cooperation to work, it must accept these political and legal constraints, build trust and 
confidence among counterpart regulators so they see that their transatlantic partner can help 
them do their work better, and provide tools to help regulators on both sides make informed 
decisions while retaining their regulatory autonomy and accountability to their politicians and 
citizens. A TTIP that provides these tools – and some more detailed instruments to that effect 
– will be more ambitious than previous trade agreements, and should, over the longer term, 
provide both the economic and regulatory benefits that the two sides envisage. The paper 
incorporates comparisons with the relevant chapters of recent FTAs the US and the EU have 
concluded, so as to clarify the approaches and degrees of ambition in this area. This 
comparison suggests that the TTIP regulatory cooperation will probably be more ambitious in 
terms of commitments and have a wider scope than any of these FTAs.   
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This time it’s different: 
Turbo-charging regulatory cooperation in TTIP 
Peter Chase and Jacques Pelkmans* 
Paper No. 7 in the CEPS-CTR project “TTIP in the Balance’’ 
and CEPS Special Report No. 110 / June 2015 
1. Introduction 
When in June 2013 Presidents Barroso, Obama, and Van Rompuy formally called for the 
launch of negotiations toward a “comprehensive and ambitious” Transatlantic Trade and 
Investment Partnership (TTIP) between the United States and the European Union, the 
regulatory part of the agreement was widely heralded as being the most novel, and the most 
important for generating economic growth.  
Two years and nine rounds of negotiation later, TTIP’s regulatory component is one of the 
more contentious parts of the agreement, both because of persistent differences in emphasis 
between the negotiators, and because of concerns that regulatory cooperation could lead to a 
lowering – or, for that matter, an unjustified raising – of consumer, worker, prudential, and 
environmental standards.1 
In contrast, the authors believe that regulatory cooperation between the United States and the 
European Union is primarily about enhancing the ability of EU and US regulators to protect 
their citizens; positive economic gains are a secondary, if important, result. This paper starts 
by presenting a framework to understanding regulatory cooperation in general, and briefly 
discusses developments in US and EU regulatory cooperation since 1995, before presenting, 
in sections 3 and 4, how TTIP can ‘turbo-charge’ this by enshrining good regulatory principles 
and practices, and by introducing new tools to deepen the relationship between transatlantic 
regulators. Sections 5 and 6 compare this proposal with regulatory provisions in previous US 
and EU trade agreements, as well as with those the EU Commission has recommended for 
TTIP. 
The central thesis throughout the paper is that regulatory cooperation between the United 
States and the European Union should be about helping regulators become more efficient and 
effective in achieving their goals, and not primarily about removing or reducing ‘non-tariff 
barriers to trade’.2 While TTIP can help ensure that regulators are better informed about the 
                                                   
* Peter Chase is a former US diplomat, non-resident Fellow of the German Marshall Fund and Vice 
President for Europe at the US Chamber of Commerce; Jacques Pelkmans is Senior Fellow at CEPS. This 
paper reflects the personal views of the authors. The authors are grateful to several persons who have 
made useful comments and suggestions, but these persons prefer not to be named. 
1 Note that ‘standards’ here refers to regulatory objectives (e.g. about health, safety, etc.), which the 
debate has sometimes informally called ‘level of protection’.  
2 This paper focuses on the regulatory cooperation as a general matter, rather than on such regulatory 
issues that are traditionally covered in trade agreements -- sanitary and phyto-sanitary standards, 
technical barriers to trade such as standards and conformity assessment, etc., although these will of 
course also be incorporated in TTIP. For SPS and agri-food in TTIP, see Josling & Tangermann (2014); 
for the TBT chapter in TTIP, see Pelkmans (2015b). 
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consequences of their decisions for the transatlantic partner, it must also recognise that 
changes to regulation must go through our respective domestic decision-making procedures, 
that the regulators are, and will remain, under political oversight, and that they must retain 
their autonomy to make decisions appropriate to their jurisdictions, even if those decisions 
create divergences. This understanding addresses public concerns about transatlantic 
regulatory cooperation even as, we believe, TTIP will motivate the regulators to do more of it, 
with all the benefits that this might bring. 
2. Regulatory cooperation: What it is and what the EU and US have 
achieved so far 
2.1 Introducing international regulatory cooperation 
As a bilateral agreement between two governments that will provide for some regulatory 
cooperation, TTIP represents merely one form of international regulatory cooperation (IRC), 
and must be understood in that context.  
Governments have engaged in various forms of regulatory cooperation for decades, in 
everything from informal memoranda of understanding to full international treaties. 
International regulatory cooperation is pursued bilaterally (e.g. Regulatory Cooperation 
Councils between the US and Mexico and the US and Canada), multilaterally (the OECD MAD 
program on the acceptance of chemical data), in global quasi-hierarchies that provide 
regulatory ‘models’ and strong incentives for voluntary implementation (e.g. financial 
regulation in the G-20 and the Financial Stability Board) and internationally (as treaties such 
as the Montreal Ozone Protocol, and in such international organizations as APEC, OECD, 
WTO (especially the SPS and TBT agreements), UN-ECE (on selected ICT standards, like 
Bluetooth, and car regulation), and ICAO (on safety in aviation and on minimum 
environmental requirements). International regulatory cooperation also happens in private 
international organisations such as ISO (on technical standards) and ILAC (on laboratory 
accreditation with recognition of conformity assessment results based on strict ILAC/ISO 
standards). International organisations for regulators have also emerged, such as the 
International Medical Devices Regulatory Forum, which focuses on global standards as well 
as a harmonised format of product-registration submissions, and, in medicines, the PIC/S (on 
common rules for inspections3) and the International Conference on Harmonisation (ICH) of 
technical aspects of marketing approval of medicines, which has issued some 50 guidelines. 
This selective list shows that international regulatory cooperation has grown in importance 
and variety, at different levels and with a range of instruments. The OECD (2013a) has done 
an extensive stock-taking of these various forms of IRC, and has mapped eleven distinct forms. 
A convenient summary of the OECD mapping is depicted in Figure 1, which distinguishes not 
11 but 12 mechanisms and presents international regulatory cooperation as a ‘ladder’ of 
increasing ambition, from non-binding and very loose mechanisms at the bottom to stringent, 
binding, and demanding ones at the top.  
                                                   
3 See www.picscheme.org  
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Figure 1. The ladder of international regulatory cooperation 
 
The bottom four rungs of the ladder show ‘soft’ - that is non-binding – IRCs, which can 
degenerate into a ‘talk-shop’ if left on their own. With respect to Step 2, principles of ‘good 
regulatory practice’ have been developed in the OECD 2012 Recommendations on Regulatory 
Policy and Governance4 (and accepted by both the US and the EU). Recognition of 
international standards (Step 3) is in the WTO TBT Agreement, but this obligation is not ‘hard’ 
or easily enforceable given the long-standing discord between the US and the EU about the 
definition of an international standard. The EU is of the view that ‘international standards’ are 
written and promulgated by established international bodies (like ISO and IEC) while the US 
believes the Agreement has a much broader application.5 The economic meaning of Step 3 can 
be rendered much more powerful if done in conjunction with Step 4, which requires the 
explicit consideration of international effects when drafting a domestic regulation which might 
affect trade. Depending on the stringency of the agreed obligations, and without undermining 
each party’s autonomous ‘right to regulate,’ Step 4 can go quite far.  
Trans-governmental networks of experts and regulators (Step 5) have become important too, 
both in EU/US relations and embedded in broader country participation. The International 
Competition Network, for example, goes beyond the EU and US but has been strongly 
influenced by the two parties. This is also true in the Bank for International Settlement’s Basel 
Committee on banking supervision, which has a wider membership but remains dominated 
by the EU and the US. Regulators in medicines and medical devices have also developed 
multilateral or global forums, based in part on initial US-EU bilateral cooperation. This 
                                                   
4 See www.oecd.org/gov/regulatory-policy/49990817.pdf  
5 This point is elaborated in Pelkmans (2015b).  
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7.       MRAs= mutual recogni on agreements  (on conformity 
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6.        intergovernmental organiza ons, structural IRC on tax, health, 
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4  CHASE & PELKMANS 
 
suggests that Step 5 may work bilaterally sometimes, but with global markets and global value 
chains, the bilateral context could become a stumbling block or be seen as insufficient.  
The same may well apply to Step 6 on international organisations. In general, EU-US 
cooperation is essential to regulatory cooperation in these multilateral forums because work 
in large international organisations is frequently shallow and soft, hampered by the resistance 
of some members and/or a divergence in underlying policy objectives. And where IRC in such 
organisations is successful, it can take years, if not decades, of prudent approximation. A good 
example of long-winding but eventually successful IRC is the binding OECD MAD agreement 
on mutual acceptance of chemical safety test data, which took decades.  
In Step 7, mutual recognition of conformity assessment, the EU and US took the lead in the 
early 1990s, but several other countries caught up on the basis of the EU-US model, the 
experiences and lessons of which are summarized in Box 1 below. Mutual Recognition 
Agreement (MRAs) on conformity assessment do not affect or put in question any aspect of 
either party’s regulatory regime. Even so, MRAs on conformity assessment are more 
demanding in that they are also treaties, hence ‘hard’ law. Equivalence agreements are another 
option mentioned in the WTO TBT Agreement and the 1998 US-EU Veterinary Equivalence 
Agreement has been partially successful [see Josling & Tangermann (2014) for assessment].  
Step 8 (regulatory partnerships) is ill-defined. The partnerships may amount to an ambition 
greater than MRAs (hence, Step 8 on the IRC ladder) but that is far from certain. Thus, Canada–
US regulatory cooperation (with a Council to that effect) is not binding and characterised more 
by the ambitions and methods of Steps 4 and 5. Such voluntarism may still yield results, 
though, especially as cooperating regulators build trust in each other and confidence in the 
partners’ rules and enforcement ability. For regulatory partnerships to be as strong and 
effective as Step 8 would suggest, one would need to specify in much greater detail what 
regulatory principles, opportunities, disciplines, and cooperative obligations the parties 
subscribe to in a treaty or other legally-binding agreement. .  
The other steps in the IRC ladder of Figure 1 all go even farther. Step 9 is about narrow treaties 
which bind countries in a specific area or sector. A leading and successful example is the 
Montreal Convention on protecting the ozone layer by forbidding or restricting F-gases. Other 
similar conventions are less successful because they have been drafted in far more circumspect 
language and with exceptions, carve-outs and other exclusions, or, like UNFCCC, form no 
more than a general framework for very long-term cooperation (here, on mitigating climate 
change).  
Step 10 on mutual recognition more broadly is even more ambitious. At this level, mutual 
recognition agreements can stipulate that when the objectives and enforcement of safety, 
health, environment, investor/saver and consumer protection (SHEIC) risk regulation are 
‘equivalent’, home rules of the exporting countries are regarded as sufficient guarantee for 
allowing market access into the importing country.6 Thus, here, the equivalence does not refer 
to a case-by-case examination of product types by the importing country, in the framework of 
an ‘equivalence agreement’ (Step 7), but refers to policy objectives. This goes much further and 
has fairly radical implications.  
                                                   
6 Extensive analyses of mutual recognition can be found in Pelkmans (2007) and (2012) based on the EU; 
the practice of MR in Trans-Tasman MRA is analysed in Pelkmans & Correia de Brito (2015a, annex C).  
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One huge misunderstanding about mutual recognition is that it might lead to less or less 
ambitious regulation, once the rules of the exporting country are determined ‘sufficient’. This 
misunderstanding is based on the famous quote from the 1979 Cassis-de-Dijon case,7 but that 
quote assumes equivalence of objectives first. In this sense, mutual recognition is about 
overcoming different technical specifications that reach an equivalent regulatory objective – 
the latter refers to the market failure that matters and is addressed by that objective; the 
instruments or technical details are not decisive and should not be (in other words, they may 
differ).  
Steps 11 and 12 are not expected to apply to TTIP as a rule. One should consider Step 11 as far 
more stringent, perhaps even somewhat centralising, than Step 8 (regulatory partnerships). 
For instance, the Australia-New Zealand ‘Trans-Tasman’ Mutual Recognition Agreement 
builds on mutual recognition but this is occasionally combined with common rules and, in 
food, with a common enforcement agency. Step 12 proposes harmonisation as a regular 
element of economic regionalism. TTIP is not meant to assume such ambitions and it is almost 
certainly not even desirable as a rule. But there are isolated instances of harmonisation 
between the US and the EU which, perhaps surprisingly, have emerged from international 
organisations (Step 6) and/or specific agreements. One example is far-reaching harmonisation 
of maritime safety rules in the IMO. As a result, the EU and the US have concluded a separate 
MRA in 2004 on 49 types of maritime equipment, which works well.  
The OECD study and Figure 1 underscore that negotiators and regulators have to think in 
terms of many different forms for international regulatory cooperation. The spectrum 
comprises many options, and each option has stringent and less stringent variants. And 
although one might be correct in suspecting that ‘soft’ steps near the bottom of the ladder tend 
to be less effective, this is not always the case. For instance, regulators are loath to bind 
themselves in treaties and hence might opt for the lower steps in their cooperation. But as 
shown in medicines and medical devices, the voluntary follow-up in national regulatory 
regimes of what has been agreed in such sectorial regulatory forums has been active, and many 
countries adopt such guidelines or allow acceptance of single-form submissions. Regulatory 
cooperation in TTIP can benefit from these insights as well.  
An important conclusion of the sophisticated mapping in the OECD international regulatory 
cooperation study is that despite “…the growing trend in regulatory cooperation, IRC is not 
based on a clear understanding of benefits, costs and success factors of the various IRC 
options” (OECD, op. cit., p. 75). This warning must be kept in mind for regulatory cooperation 
as we look briefly at the history of US-EU regulatory cooperation, and lay out how it could be 
developed in TTIP. It should be clear in any event that TTIP can be based on, or linked to, 
many such international initiatives or regimes, or, indeed, it might assume a longer-run 
process of enhancing the ambitions of such IRC by setting more ambitious TTIP objectives as 
a leading example. 
                                                   
7 EU Member States must allow ‘a product lawfully produced and marketed in another Member State 
into their own market’. Case C-120/78. As formulated, this is the pure origin principle. However, one 
must read this in conjunction with the logic of the derogations for Member States, which are ‘justified’ 
if certain regulatory objectives will not be fulfilled. However, the mutual recognition logic consists of 
establishing whether the objectives of another Member State are equivalent (even when not identical) 
in providing regulatory protection; if so, the origin principle prevails and imports cannot be blocked. 
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2.2 Recent US-EU regulatory cooperation: A bird’s eye view 
While US regulators have been working with their counterparts in major EU member states 
for many years, cooperation with EU-level counterparts began with the Joint Statement on 
Regulatory Cooperation at the end of 1997,8 followed a year later by the ‘Agreement on Mutual 
Recognition Between the European Community and the United States of America.’9  
As described in Box 1 below, these first agreements were generally limited in scope, applying 
mainly to recognition of certain laboratories being able to test whether locally-produced 
products in six sectors (in the 1998 MRA) met the regulatory requirements of the other party.  
 
Box 1. The 1998 US-EU MRAs and lessons drawn 
As one of their first full forays into bilateral regulatory cooperation, the US and EU concluded a 
Mutual Recognition Agreement (MRA) on conformity assessment in 1998. The MRA has a 
general set of principles, rules, and procedures in a ‘chapeau’ or ‘umbrella,’ with six distinct 
annexes in the sectors: telecoms equipment, electromagnetic compatibility (EMC) of equipment 
and appliances, electrical safety of goods (including machinery), pharmaceutical Good 
Manufacturing Practices (GMP), medical devices, and recreational craft. Consistent with the 
practices in Step 7 above, this MRA had the limited objective of allowing designated Conformity 
Assessment Bodies from each party to certify that products in these sectors met the regulatory 
requirements of the other party. As such, it reflected a conscious choice not to engage in any 
regulatory change but to focus solely on reducing transaction costs for market access. The 
economic gains from such limited MRAs tend to be relatively small, unless the costs of 
conformity assessment amount to a considerable surcharge on the export price. After carefully 
reviewing the experience with the MRA, Pelkmans & Correia de Brito (2015b) find: 
1. Despite great initial efforts, only three of the six sector MRAs are operational: telecoms 
equipment, electro-magnetic compatibility, and recreational craft. In terms of trade values, the 
three MRAs that work cover only one fifth of the bilateral trade originally foreseen under all six 
sectorial MRAs. In the other three – pharmaceuticals, medical devices, and electrical equipment 
– the initial trade policy focus was probably unsuitable for what was seen by US regulators as a 
loss of control of properly serving their regulatory objectives. Regulators should therefore play 
a major role in designing regulatory cooperation, even in the case of MRAs, whilst trade policy 
may generate collateral benefits but cannot be decisive.  
2. MRAs are easier in markets which are less heavily regulated, but ironically, in these cases they 
are also less needed because alternatives to MRAs (in particular, suppliers’ declarations of 
conformity, or SDoCs) can serve as a low-cost and swift solution. When SDoCs are not permitted, 
alternatives such as subcontracting may nevertheless be used by market players. Thus, in 
particular, large US and EU exporters with a steady customer base (or as part of a value chain) 
in the EU and US have a great interest in durable relationships with trusted CABs. The practical 
working of the MRA will then be significant only for new entrants or occasional exporters or in 
                                                   
8 “Regulatory Cooperation: Facilitating Trade while Promoting Consumer Protection,” Joint Statement 
released in conjunction with the US-EU Summit in Washington, DC, 5 December 1997, 
www.eurunion.org/partner/summit/Summit9712/regulst.htm. 
9 Found at http://trade.ec.europa.eu/doclib/docs/2003/october/tradoc_111718.pdf.  
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cases of overload. New entrants may well be SMEs, so for them and possibly the emergence of 
‘new’ competition, the MRA would still fulfil a useful function.  
3. MRAs in heavily regulated markets require a considerable degree of convergence in desired 
levels of protection as well as a gradual build-up of trust and confidence between the regulators. 
This did not work at first for medicines and medical devices. There are also indications that at 
the time, in these two sectors, the EU internal market rules and supervision still left something 
to be desired. Simultaneously, at world level, cautious attempts were initiated to come to greater 
harmonisation for pharmaceuticals and medical devices 10 in some respects, such as similar data 
and shorter time-to-market, in which the EU and the US played a leading role. These alternative 
IRC tracks have meanwhile become quite successful, thereby more or less obviating the 1998 
MRA provisions. 
4. In electrical goods safety, the third sector which failed (the MRA was suspended by the EU in 
2003), the EU attempted in 2008 to convince OSHA (the US regulator for occupational health and 
safety, including electric goods and machinery used in the workplace) to accept SDoCs from EU 
producers. SDoCs are a form of self-certification customary in the EU ‘New Approach’ to 
reducing regulatory barriers in the single market. After a two-year investigation, OSHA 
concluded that the empirical evidence about equivalent or better risk reduction in the EU was 
insufficiently convincing. This experience underscores that regulators will only enter into 
agreements with their counterparts where hard evidence exists that both the rules and the 
enforcement of those rules demonstrate that the counterpart’s approach delivers similar 
regulatory outcomes. .  
Source: Pelkmans & Correia de Brito (2015b). 
 
These efforts were heavily backed by industry, and in particular the Transatlantic Business 
Dialogue (TABD), which the US and EU had helped create with the 1995 ‘New Transatlantic 
Agenda’, in part to encourage more direct business engagement and advice in transatlantic 
trade matters. (Transatlantic Dialogues for consumers, labour, and the environment were 
established a few years later.) At this time TABD was also strongly encouraging great 
regulatory cooperation in automotive safety. This failed when the US regulator (the National 
Highway Transport Safety Agency, NHTSA) undertook extensive studies about certain 
specific auto safety features (e.g., on standards for side door crash resistance) which 
demonstrated that EU vehicles were less safe than their American counterparts. This 
experience again underscores some of the lessons learned in the earlier MRAs – that regulators 
cannot and will not lower safety standards just to promote trade, and that they depend on 
hard evidence, rather than political good will. 
Despite setbacks, more substantive cooperation began to take off with the first US-EU 
‘Regulatory Cooperation Roadmap’ in 2002, which was successively expanded from six sectors 
to sixteen over the next three years. An important component to this was a consensus in 2002 
on good regulatory practices, which helped strengthen the cooperation and which also helped 
spur greater dialogue between the US Office of Information and Regulatory Affairs (OIRA) 
and the Commission’s Secretariat General, which also oversees better regulation in the EU. 
                                                   
10 The Global Harmonisation Task Force for medical devices, active since the mid-1990s, and the 
International Conference on Harmonisation of Technical Requirements of Pharmaceuticals for Human 
use (ICH), founded in 1989. For more detail, see Pelkmans & Correia de Brito (2015b). 
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This experience eventually helped in the establishment of the US-EU High Level Regulatory 
Cooperation Forum (HLRCF) in 2005 to further promote best practices in such cooperation.  
By 2007, when the Transatlantic Economic Council (TEC) was founded, transatlantic 
regulatory cooperation was booming. For example, at that time the US Food and Drug 
Administration (FDA) informally estimated that its officers were having over 1,000 
substantive contacts a year with their European counterparts in DG SANCO, the European 
Medicines Agency (EMEA), and the European Food Safety Authority (EFSA).  
Annex 1 provides a detailed summary list of all the US-EU regulatory cooperation initiatives 
we have been able to identify since the first agreement on regulatory principles in 1997. This 
growing cooperation has had a number of significant results, both broadly as with the 2008 
report comparing US and EU approaches to import safe products,11 and in individual sectors, 
from the November 2007 FDA/EMEA decision to accept a single application for orphan 
drugs,12 to the 2008 US Securities and Exchange Commission’s (SEC) decision to accept the 
EU’s international accounting standards as equivalent for US capital markets purposes.13 One 
of the most ambitious examples was the conclusion in 2009 of the US-EU Bilateral Aviation 
Safety Agreement,14 under which the FAA and the European Aviation Safety Agency (EASA) 
agreed to accept one another’s air-worthiness certifications for Boeing and Airbus airplanes, 
even though an aeroplane is arguably the most regulated product on the market and even 
amidst an intense WTO trade dispute on the supports both sides give to their respective 
companies. In 2012, the two governments concluded other agreements, including mutual 
recognition of their respective approaches to organic produce15 and to container and air cargo 
supply chain security systems,16 as well as joint work in such areas as electric vehicle safety 
and design requirements. 
While the breadth and depth of US-EU regulatory cooperation has been growing, it tends to 
be technical, and thus known only to those directly engaged in the sectors concerned. Because 
of this, many outside these areas tend to be sceptical – and at times outright critical – of the 
cooperation. This may underscore the need for a more basic understanding of what regulatory 
cooperation is and should be about between the United States and the European Union. 
                                                   
11 See ‘Toward Enhanced Cooperation between the European Union and United States of America on 
the Safety of (Imported) Products’, 
http://ec.europa.eu/enterprise/policies/international/files/tec_safety_en.pdf. 
12 See EMEA press release, “The European Union and FDA Working Together to Create a Single 
Application for Orphan Designation for Medicines”, 26 November 2007, 
www.emea.europa.eu/docs/en_GB/document_library/Press_release/2009/11/WC500011002.pdf. 
13 See www.sec.gov/rules/final/2007/33-8879.pdf  
14 See www.faa.gov/aircraft/repair/media/Safety_Agreement_Between_US_and_EC.pdf  
15 See www.ams.usda.gov/AMSv1.0/getfile?dDocName=STELPRDC5097063  
16 See www.cbp.gov/newsroom/national-media-release/2013-02-08-050000/eu-us-fully-implement-
mutual-recognition-decision  
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3. Basic principles and motivation for TTIP regulatory cooperation 
The primary role of governments in modern societies is to protect their citizens – from foreign 
aggression and domestic crime, of course, but also from abusive labour practices, unhealthy 
environments, and unsafe products and services.  
This last function is the most relevant aspect when it comes to trade across borders. But here 
it needs to be emphasised that the job of regulators is to pre-empt or prevent any market 
exchange which has unacceptable adverse effects on consumers or workers, or the 
environment. Regulators want to prevent unsafe products and services from getting into the 
domestic market whether those products or services are produced at home or abroad.17 
The level of safety that a regulator demands is primarily a function of the political system and 
income levels in a society.  
 Politically, in countries with little or no input from citizens, the desired levels of safety 
will reflect the preferences of government officials; in an autocratic dictatorship, the 
preference of the ruler. In democratic societies, however, with a transparent and rules-
based approach to governance, the level of safety demanded in regulation will in general 
reflect the risk preferences of the voters as expressed in elections. In this sense, democracy 
is not just a ‘value’, but has a very real operational significance with respect to regulation.  
 Economically, increasing levels of protection costs money, and governments need to 
balance these costs with the benefits in terms of safety that regulation can bring. In a 
democratic society where the levels of protection will reflect the polity at large, the degree 
of safety demanded will therefore tend to be a function of income – the higher the level of 
income, the less important the additional costs of risk mitigation and the higher the level 
of protection demanded. This is a wholly domestic affair – democratic governments will 
regulate to the risk preference demanded by their voters even in the absence of imports 
from another jurisdiction. 
This somewhat theoretical discussion is directly relevant to the issue of regulatory cooperation 
in TTIP. As democratic societies with comparable levels of income and wealth and transparent 
and politically accountable18 regulatory systems, the United States and the European Union 
have in general identified the same sorts of goods and services as posing risks to their citizens 
(and voters), and strive for the same level of safety in those areas—that is, their regulatory 
objectives and outcomes are generally similar.  
This general observation is based on both impressions and empirical studies. 
Impressionistically, over 25 million people travel each way between the United States and 
Europe each year, staying in hotels, eating local foods, renting cars, buying products, and 
                                                   
17 Governments may of course also regulate international trade to minimise the economic risks of 
competition from foreign firms, otherwise known as protectionism. That aspect of risk mitigation is not 
considered here, as both the US and the EU nominally eschew it. 
18 In the United States, Congress actively oversees the activities of US regulatory agencies. In the 
European Union, the Council, representing the elected governments of the 28 member states, ‘co-
decides’ the level of safety in regulation with the directly elected European Parliament, while member 
state governments and parliaments will be the ‘first responders’ to failures in market surveillance and 
enforcement. For an authoritative and detailed exposition of the US and EU regulatory system, see 
Parker & Alemanno (2014). 
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otherwise engaging in daily activities; they do not seem to perceive any difference in the level 
of safety provided. More academically, a 2010 study published by Resources for the Future, 
based on 20 case studies and 3,000 observations of risk-reducing regulatory decisions in the 
US and EU, found that overall risk stringency is about the same, with the differences largely 
due to non-safety related issues.19 
It is precisely this political and economic foundation that permits, and indeed encourages, a 
truly ambitious level of regulatory cooperation in TTIP. US and EU legislators and regulators 
have traditionally determined the level of safety they desire based on domestic costs and 
benefits. The US and EU economies are so tightly integrated, however, that these inward-
looking approaches are insufficient, missing both the costs and the benefits of the transatlantic 
implications of these domestic choices. The European Union and the United States have the 
largest trading relationship in the world, with over $1 trillion in two-way trade in goods and 
services each year. Further, US firms have invested over $2.3 trillion in the European Union, 
while EU firms have invested some $1.7 trillion in the United States. These investments 
together generate nearly $5 trillion in sales each year. Nearly half of all trade is intra-industry 
and intra-firm. When legislators and regulators on either side make decisions without 
considering this integration, even if they are separately trying to achieve the same level of 
safety, they may do so in ways that require products and services to be designed and produced 
differently to be sold in each market.  
This raises costs to producers, at times to the point where they cannot profitably supply a 
product or service to the other side of the Atlantic. This is particularly so for smaller firms, 
many of which only know that the regulatory requirements and standards are different, and 
don’t have the ability to research or re-tool to meet them. But it also affects large firms – the 
cost of crashing over a hundred custom-made models to meet different safety, testing, and 
certification requirements in automobiles, for instance, run to hundreds of millions of euros. 
This makes it almost impossible for smaller French and Italian car manufacturers to sell into 
the US market. The same can happen for medicines, especially for rare illnesses. And this, of 
course, raises costs to consumers, who may be wholly denied products and services that they 
wanted or needed. One of the most politically interesting examples was the pressure put on 
the FDA in the 1980s-90s to fast-track approval of HIV medicines that had been working 
effectively in Europe for years. And both societies as a whole lose the gains in productivity 
that would come from more companies competing in their markets, and the advantages of 
synergy and global competitiveness that firms working on both sides of the Atlantic could 
have if they did not face these ‘unnecessary’ regulatory divergences: ‘unnecessary’ in the sense 
that the intended levels of safety are similar (see also Box 2).  
The disadvantages of insufficient consideration of the transatlantic costs and benefits of 
greater regulatory compatibility between the United States and the European Union are, 
however, only one part of problem. Potentially more important is the adverse impact on the 
regulators themselves, and their ability to achieve their goal of keeping their citizens safe. 
Regulators devote their resources to ensure that rules are being observed for the products and 
services being sold in their market. The enormous volumes of transatlantic trade require a 
correspondingly large amount of resources to police. At the same time, globalisation has also 
greatly increased trade with many other partners. With ever-increasing volumes of imports 
                                                   
19 Jonathan B. Wiener, Michael D. Rogers, James K. Hammitt and Peter H. Sand (eds), The Reality of 
Precaution: Comparing Risk Regulation in the United States and Europe (RFF Press, December 2010).  
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from other - potentially more risky - jurisdictions, sophisticated and ever-lengthening supply 
chains, and ever-decreasing budgets, the regulators are in danger of being stretched too thinly 
to do their job. If, however, they have evidence demonstrating that their transatlantic 
counterparts are able to enforce levels of protection similar to their own, they can develop a 
partnership with that counterpart regulator, allowing them to focus their enforcement 
resources on higher-risk problems. Indeed, it was precisely this broader gain from 
international regulatory cooperation that motivated President Obama to issue Executive Order 
13609,20 encouraging US regulators to be more active in this, especially with places like the EU 
that share US regulatory values.  
The ability for enhanced transatlantic regulatory cooperation to increase the efficiency and 
therefore the effectiveness of US and EU regulators is one of the most misunderstood benefits 
of TTIP, even by some of the regulators themselves. For given their political accountability at 
home, whether to Congress, the European Parliament or the EU member states, their ability to 
cooperate with a foreign counterpart is directly proportional to the level of trust and 
confidence that they have in that counterpart. And that comes only with time and experience. 
In this sense, the United States and the EU are now better positioned for an ambitious approach 
to regulatory cooperation in TTIP, as the US and EU regulatory systems have improved, and 
as regulatory cooperation has grown over the past 15 years.  
Box 2. Potential economic gains from regulatory cooperation in TTIP 
In the sense of our discussion above, many of the gains from regulatory cooperation cannot be 
easily measured. However, a number of empirical economic simulation studies on TTIP have 
been published in 2013 and 2014; two - Francois et al., (2013) for the Commission Impact 
Assessment, and Fontagne et al. (2013) -  explicitly study TTIP regulatory cooperation in detail. 
These two studies, both of which are based on a broader ECORYS study from 2009, attempt to 
estimate the costs of regulatory differences as a percentage of export invoice costs (the so-called 
‘tariff equivalent’ of technical barriers to trade, or TBTs). The studies estimate these TBT tariff 
equivalents between the US and EU to range from 15% - 72% depending on the sector. Such 
percentages are a large multiple of US and EU nominal tariffs on industrial goods and many 
agricultural products. Francois et al., op. cit., estimates that no less than 56% of TTIP’s economic 
gains arise from an assumed 50% cost reduction of TBTs (their ambitious scenario). Even with 
the difficulty of properly estimating the benefits of TBT reduction (see Pelkmans et al., 2014) as 
well as the limitations of even the best econometric models, the reduction of TBT costs through 
regulatory cooperation is obviously important to the overall economic gains of TTIP.  
4. Turbo-charging regulatory cooperation in TTIP21 
The most important question now is how TTIP can build upon the experiences US and EU 
regulators have had over the past 15 years in collaborating with one another, given the broader 
                                                   
20 See www.whitehouse.gov/sites/default/files/omb/inforeg/eo_13609/eo13609_05012012.pdf 
last accessed on Dec. 30, 2014 
21 The comments in this section are jointly drafted but reflect the first author’s experiences in 
transatlantic regulatory cooperation as well as his work in the US Chamber; see, for instance, 
www.uschamber.com/sites/default/files/regulatory_coherence_regulatory_cooperation_-
chamber_ttip_paper_-_final_3-02.pdf, February 2015. 
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political, economic, consumer, and regulatory benefits of greater transatlantic regulatory 
cooperation.  
4.1 General Considerations 
As discussed above, the single most important consideration is understanding that regulatory 
cooperation can only work if the regulators on both sides have the full trust and confidence of 
one another, that the levels of protection are similar, and that the enforcement of those 
regulatory requirements is effective. While TTIP aims to enhance regulatory collaboration and 
compatibility, regulators in the end must make decisions that reflect the political will of their 
electorate. 
A second critical consideration is a clear delimitation of the scope of regulatory cooperation 
under TTIP. Regulatory cooperation in TTIP should focus on laws and regulations that directly 
apply to goods and services traded between the two parties. Laws and regulations that go to 
wholly domestic matters, such as those on working hours, wage levels, air pollution standards, 
etc., should be outside the scope of any general disciplines on regulatory cooperation, even 
though those measures may have an indirect effect on trade 
A third consideration which also affects the scope is that the obligations on regulatory 
cooperation in TTIP should apply to the EU Commission and the US Executive branch and 
independent agencies, not the respective legislatures (Congress in the United States, the 
Council and European Parliament in the EU). This third consideration is elaborated upon 
below. 
With these three considerations in mind, the regulatory part of TTIP (here, not counting SPS 
and TBTs, see before) should have three essential components:  
 agreement on principles and best practices in domestic regulation (sometimes referred to 
as ‘regulatory coherence’);  
 general (or ‘horizontal’) provisions governing regulatory cooperation; 
 sectorial annexes reflecting agreements that have been, and will be, agreed between 
counterpart US and EU regulators, both during and after the TTIP treaty negotiations. 
This structure, and in particular the use of sectoral annexes, is essential to the acceptance and 
functioning of transatlantic regulatory cooperation in the context of the TTIP negotiations. It 
is essential, firstly because it recognises pragmatically that trust and confidence between 
counterpart sectoral regulators is the core of regulatory cooperation;  secondly because it 
guarantees, for citizens and politicians alike, that the regulators themselves (rather than trade 
negotiators) are in charge of the details of the cooperation for which they are politically 
accountable; and thirdly because it allows the regulatory part of TTIP to be a ‘living’ 
agreement, with the inclusion of additional regulator-to-regulator agreements even after the 
TTIP is concluded, as additional experience, trust, and confidence are gained between the 
counterpart agencies. 
The remainder of this section will focus on the regulatory coherence and cooperation aspects 
of TTIP, as well as the sectoral annexes, since these are the most novel aspects of the regulatory 
part of the agreement.  
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4.2 Regulatory coherence 
The opening section of a TTIP regulatory chapter must lay out the principles and practices that 
are the foundation on which the trust and confidence of regulators are to be built – a common 
understanding of what constitutes a strong, democratically accountable regulatory system. 
This should not be difficult to draft: the US and EU have twice issued joint statements on this 
(200222 and 201123), focusing in particular on the need for transparency, stakeholder 
participation, and accountability in rule-making, as well as the need for quality impact 
assessments, evidence-based decision-making and the like, as described in Box 3 below.  
 
Box 3. US-EU consensus on Regulatory Principles and Practices 
The US and the EU have been developing a consensus on regulatory principles and practices 
since the late 1990s. In fact, its origin may be traced back to the 1995 recommendation of the 
OECD Council on Improving the Quality of Government Regulation. In addition to the 1997 US-
EU guidelines on regulatory cooperation, the three main expressions of this consensus include 
the joint statements of 2002 and 2011 noted earlier and, more recently, the 2012 recommendation 
of the OECD Council on Regulatory Policy and Governance.24 The 2011 ‘Common 
Understanding’ demonstrates that the two partners have already developed regulatory 
principles that are very similar, if not the same. The Understanding reaffirms their shared 
commitment to good regulation, and is based on EU and US documents that already guide 
domestic regulatory policy. When regulation is to be developed, it should be evidence-based 
(with impact assessment or equivalents), include an analysis of relevant alternatives, evaluate 
the effectiveness of existing regulation, and apply approaches that minimise the burden while 
aiming for simplicity. The regulatory process should be transparent and should solicit, evaluate, 
and respond to input from all stakeholders. 
Further, the 2011 Common Understanding says explicitly that “regulatory measures should aim 
to avoid unnecessarily divergent or duplicative requirements between the US and the EU, when 
appropriate.” Moreover, the US and the EU “should also explore a process to exchange 
regulatory information of the Unified Agenda and Work Programme, respectively, … and have 
a fixed agenda item at the High Level Regulatory Cooperation Forum” with a view to seeing 
whether the two parties can work together on areas both are considering. The Understanding 
also encourages new regulatory cooperation measures, and obliges both to flag upcoming 
regulatory proposals likely to have international trade and investment effects, and/or 
publishing an Annual Notice to solicit public comments.  
The 2002 guidelines are more detailed but otherwise very similar. They begin with seven steps 
which “will help minimise and resolve trade frictions and facilitate trade.” None of these seven 
steps are surprising or controversial, and are presumably often, if not always, in the domestic 
public interest, too. Among other things, they include the commitment to “pursue… 
harmoni[s]ed, equivalent or compatible solutions…. and to minimize… or eliminate 
                                                   
22 See www.whitehouse.gov/sites/default/files/omb/oira/irc/2002-guidelines-on-reg-coop-and-
transparency.pdf, April 2002 
23 See www.whitehouse.gov/sites/default/files/omb/oira/irc/common-understanding-on-
regulatory-principles-and-best-practices.pdf, June 8, 2011 
24 www.oecd.org/gov/regulatory-policy/49990817.pdf Note that, between the US and the EU, the 
starting point is still the 2011 Common Understanding. 
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unnecessary divergence in regulations” through dialogue at all phases of the regulation 
development process. Transparency is strongly emphasised, as is the need for adequate time to 
provide meaningful comments, and their reasonable consideration, on draft proposals. These 
should be performance-oriented and cost effective, and hence have fewer adverse effects. These 
and other suggestions are by now well accepted throughout the OECD. 
 
The issue being addressed in the TTIP negotiations now is how precisely the two sides think 
these principles and practices should be implemented, and indeed how to go beyond the 2011 
Common Understanding. The United States, which has emphasised the importance of the 
concepts of transparency, participation, and accountability, argues in particular that the 
Commission should publish draft legislation and regulation (‘implementing measures’ and 
‘delegated acts’ under the EU’s ‘comitology’ procedures) on the internet for comment from all 
stakeholders, and that it should then summarise and respond to the substantive comments 
and evidence provided through that process when it finalises the proposal.  
These ideas are less straightforward than they seem in the EU context. When it comes to 
legislative proposals, publication of a draft for comment prior to adoption of a proposal by the 
College of Commissioners is a sensitive issue for the Commission, as it is seen as undermining 
one of the central powers of the Commission under the EU treaties – the right to initiate 
legislation. The Commission is concerned that the member states in the Council and Members 
of the European Parliament would be among the most active participants in the public 
consultations about the drafts, which would essentially eliminate its right to initiate 
legislation. It therefore balks at making such a radical constitutional change in the context of a 
trade negotiation.  
But it should be stressed that the idea of providing an opportunity to comment on draft 
legislation is not just a request of the US government, but one made by many European 
stakeholders as well, both in the business sector, in civil society, and by a 2009 broad Task 
Force of an EU think-tank.25 As such, changes that might come about here can and should 
happen independently of TTIP, and be consistent with the Commission’s own efforts to 
improve its domestic regulatory processes. And indeed, First Vice-President Timmermans and 
the Secretariat General of the Commission are now considering responses to the June 2014 
request for comments on guidelines on the use of stakeholder input in the legislative and 
regulatory process.26 
                                                   
25 See, for instance, the many responses to the EU Commission Secretariat General’s July 1 2014 request 
for comments on draft guideline concerning impact assessments and stakeholder consultation, which 
can be found respectively at http://ec.europa.eu/smart-
regulation/impact/consultation_2014/contributions/index_en.htm and http://ec.europa.eu/smart-
regulation/impact/planned_ia/consultation_2014/contributions/index_en.htm. For the Task Force 
report, see a CEPS book on reforms of EU regulation and policy-making [Renda, coordinator, 2009, p. 
xii and pp. 36/7, as ‘idea no. 13’].  
26 As this paper was being prepared for publication, the Commission adopted ‘Better Regulation for 
Better Results – An EU Agenda’ (COM(2015) 215 of 19 May 2015, which includes an open eight-week 
comment period on Commission legislative proposals after the College adopts them; comments will be 
provided to the European Parliament and Council. The Commission will also introduce a four-week 
comment period on delegated acts and implementing measures. 
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There are a number of ways input on legislative proposals could be handled without 
endangering the right of initiative. Publishing a draft after the initial inter-services 
consultation might be one approach; at this point, the serious politics (and thus the 
sensitivities) in the Commission have not yet begun. An alternative might be to stay with the 
current system and publish legislative proposals after adoption by the College - after all, these 
are proposals that must go through the legislative process in the Council and European 
Parliament. The Commission could accept comments on the proposals for, say, 60 days; these 
comments would be published on the Commission website, and the Commission’s analysis 
and response to them could then be made available to the Council and Parliament upon formal 
presentation of the proposals to those institutions (see footnote 28 acknowledging this idea). 
In the case of such regulatory measures as delegated acts and implementing measures, where 
the Commission has considerably more authority over the proposal, the idea of publishing 
drafts for notice and comment should be far less controversial, as acknowledged in the new 
Better Regulation package of the Commission. However, these two types of technical 
implementation refer to a massive quantity of acts/measures, many of which are actually of 
little importance, so there may well be a practical issue of overload.27  
The EU too has demands of the United States when it comes to regulatory coherence. The 
legislative process in the United States appears more chaotic to Europeans than that in the EU, 
with literally thousands of bills being offered each Congress. Many of these are never acted 
on, yet can form the basis for amendments of a significant nature that (in the Senate at least) 
can often come to the floor for a vote with little or no notice, never mind an opportunity to 
comment. (That said, US legislation tends to be much more general in nature than it does in 
the EU, so that the effects on traded products and services are more likely to come later in the 
process, when legislation is implemented during the regulatory phase.)  
Under the US Constitution, the Executive branch has no control over the legislative process, 
just as the EU Commission has no control over the Council or the European Parliament. Nor 
will any of those political bodies surrender in a trade agreement their autonomy to legislate. 
This is why the third key consideration noted in Section 3 above is necessary, and one of the 
first things both sides need to do in TTIP is to recognise that they can only demand some 
semblance of coherence between the Executive and the Commission, acknowledging that the 
political and legislative process outside those two bodies is necessarily a bit messy on both 
sides.28 
Even so, the Europeans could ask the US Executive branch to take steps to make the US 
legislative process less confusing for its largest trading partner. Proposed bills are only serious 
if they are brought to the relevant Congressional committee for a hearing and mark-up. At this 
stage, the Executive branch is almost always requested to testify. If it is, and if the proposal 
                                                   
27 In COM (2015) 215 (see note 28), p. 5, the Commission writes that delegated acts can be commented 
on by stakeholders, but does not refer to, say, a selection of them. This is not the case for the other 
category where only ‘important implementing acts’ which are ‘subject to Committee opinion’ will be 
made public for comments.  
28 But legislation could still be TTIP-relevant, if the administrations on both sides can take on 
commitments and attempt to convince Congress and EP/Council to incorporate them. Also, the legal 
dichotomy between legislation and administration is not always followed in practice. Thus, recent Acts 
like the Jobs Act, the Affordable Care Act, and a recent one on cybersecurity were drafted by the 
administration and (mostly) taken over by Congress.  
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would affect a product or service traded between the US and EU, TTIP could oblige the 
Administration to alert the EU of the hearing, and provide a copy of the Administration’s 
testimony as a courtesy. In addition, if and when legislation is to be voted on, the Executive 
branch often issues a statement of the administration’s position. This too could be provided to 
the EU if the bill affects a product or service that the EU exports to the US. In both instances, 
the Office of Management and Budget (OMB) is responsible for coordinating the 
Administration’s agreed position on the legislation, and should be the point of contact for 
these efforts to enhance transparency.29 
In contrast, by law under the Administrative Procedures Act, the US regulatory process is 
already generally open for participation by any stakeholder, including those in Europe. 
Proposed rules are published well in advance; all comments must be received and published, 
and must be responded to by the regulatory agency in adopting its final rule. Violations of 
these procedures can – and frequently are – brought before administrative court, which can – 
and frequently does – require the agency to undertake additional evaluation before a rule is 
implemented. The system is not perfect30 (no system is), but it is generally open, transparent, 
and accountable. 
In addition, for the US side to truly provide coherence, it must recognize that TTIP must also 
cover the activities of US ‘independent’ regulatory agencies. These agencies, generally known 
as Commissions (Federal Communications Commission, etc.), are outside the Executive 
branch and answer to both Congress and the President. Although such Commissions do not 
and legally cannot come under OMB, and so will need to be treated differently in some 
respects, the legislation that implements TTIP can provide Congressional assent to bring them 
into the scope of transatlantic regulatory cooperation. This is particularly important in the 
context of financial services regulation. 
The EU too must assure institutional coherence by fully including its autonomous Agencies 
(the European Chemicals Agency, the European Food Safety Agency, the European Banking 
Authority and the like) in TTIP, for while these are, strictly, not rule-making bodies (but often 
risk assessors), they are instrumental and increasingly influential in the rule-making process 
and/or as supervisors. Legally, the EU might not follow our advice to include these agencies 
fully, as they are not independent regulators, but we advocate the strongest possible 
involvement, without affecting ultimate regulatory responsibility.  
4.3 Regulatory Cooperation 
While the regulatory coherence part of TTIP should help improve both sides’ understanding 
of and trust and confidence in the domestic rule-making procedures of the other side, the 
regulatory cooperation part should establish obligations that apply generally to all regulatory 
agencies on both sides to ensure that their decisions are informed about the impact of 
proposals on the transatlantic partner. And, as noted above, it should also include annexes 
that reflect regulator-to-regulator agreements in specific product and service areas. 
                                                   
29 In fact, this procedural courtesy is already often practiced with respect to the Commission and the 
OMB already de facto coordinates.  
30 See, e.g., statement of Michelle Sager, Director, Strategic Issues, Government Accountability Office, 
before the US Senate Committee on Homeland Security and Governmental Affairs, March 11, 2014, 
found at www.gao.gov/assets/670/661540.pdf  
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Again, it’s important to re-emphasise here the three considerations spelled out in Section 3 
above: the need to explicitly affirm regulator autonomy, primarily through the use of the 
annexes; the focus on regulations that directly affect products and services that are or could 
be traded between the United States and the EU; and the application of these regulatory 
cooperation commitments to the Executive branch and independent agencies in the United 
States, and the Commission and relevant autonomous agencies or advisory bodies in the EU. 
Within this scope, the horizontal regulatory cooperation provisions of TTIP should: 
 establish the explicit goal of making US and EU regulatory regimes increasingly 
compatible;  
 provide the necessary tools to regulators to achieve this; and 
 create an institutional framework to oversee and guide this process. 
The goal should be simple, and unbounded by time. It provides a direction to the ongoing 
regulatory cooperation process, but should not mandate that that goal must be achieved in all 
instances (it won’t). Further, it cannot be subject to a timetable, in the recognition that building 
trust and confidence between counterpart regulators takes time, and indeed can be quickly 
lost. TTIP will set the trajectory for greater and deeper collaboration, but it will not reach an 
end-point, for among other things, laws and regulations in our society are and should be 
dynamic (in contrast, for instance, with the static tariff levels that are a normal subject of trade 
talks).  
The ‘tools’ that should apply to all sectors falling within the specified scope should both inform 
the individual sectorial agreements and the regulatory processes of each side. Among other 
things, they should explicitly provide regulators on either side the legal authority to enter into 
agreements with their transatlantic counterpart, consistent with their existing legislative 
authority and on the understanding that such agreements will be subject to political oversight 
on either side. It should also affirm that all regulator-to-regulator agreements under TTIP can 
be suspended immediately, should something happen that leads a regulator on one side to 
lose confidence in the other, and that the agreements can be unilaterally terminated within a 
specified period of time, should the trust and confidence not be restored following 
consultation. 
But more specifically, the general disciplines should ensure that regulators on both sides of 
the Atlantic are better informed about the costs and benefits of their domestic regulation as it 
affects the other party, and the trade in goods and services between them. This applies to both 
proposed new regulation, and to existing regulatory provisions affecting products and 
services. In both cases the objective is to inform decisions, not to determine them. While better 
informed of the transatlantic consequences, the regulator will in the end make the choice 
appropriate for its jurisdiction.  
For new regulations that will (a) have a significant cost of compliance to the economy and (b) 
affect a product or service in which there is a significant amount31 of transatlantic trade, TTIP 
should mandate that regulators include a regulatory compatibility assessment (RCA) in the 
                                                   
31 What is meant by a ‘significant’ amount of trade could be defined in the agreement, for example, if a 
regulation would affect a product or service where there is $100 million or more of trade. This level 
could even be sliding (from, say $500 million to $50 million) over a period of time to allow regulators to 
grow accustomed to the process. Indeed, it might be worthwhile to have different values of 
‘significance’ for different sectors. 
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impact assessment process they would normally undertake in any event. While the details and 
methodology of this would need to be spelled out in more detail, the RCA would, in any case, 
(a) require the regulator to contact its transatlantic counterpart; (b) ascertain whether the 
product or service is regulated on the other side of the ocean; (c) determine whether the 
counterpart had a similar or different definition of the problem the regulation is meant to 
address; (d) assess whether the proposed approach is compatible with that of the counterpart; 
and (e) evaluate the costs and benefits of adopting a non-compatible approach. As this impact 
assessment is to be made available for public comment, all stakeholders would be able to see 
and provide new evidence related to the RCA. Again, a non-compatible approach that would 
affect trade between the two parties could be adopted, but the decision would be informed by 
an evaluation of the consequences of this for transatlantic trade. 
For existing regulations, TTIP could establish a regulatory equivalence assessment (REA) 
process. Under this process, interested parties could send a petition to the relevant regulator 
stating that the levels of safety, or the required tests or manufacturing processes, for a specified 
product or service (or groups of products or services) achieve the same regulatory outcomes 
on both sides of the Atlantic. The petition should be accompanied by evidence supporting the 
contention of equivalence. The regulator receiving the petition would share it with his or her 
counterpart, and both would publish the petition and the evidence provided for public notice 
and comment. The two would then review the responses, and hold hearings on them. They 
would then write a joint or separate report in response to the petition, including what, if any, 
follow-on steps they would propose. Again, there would be no requirement that any specific 
result comes from this. 
The RCA and REA procedures would be applicable to all regulated sectors, including, for 
instance, financial services. But, as noted above, they would not jeopardise a regulator’s 
autonomy, only ensure better informed regulatory decisions. If agreements for enhanced 
regulatory cooperation emerge from the process, those agreements (after going through the 
appropriate domestic approval process) could then be reflected in the relevant TTIP sectoral 
annex. 
Arguably, regulators on both sides are already meant to consider the trade implications of 
their proposed regulations, and additional transparency, participation and accountability 
would help provide information about these impacts. Further, regulators on both sides 
probably already could receive and consider petitions asserting equivalence. But enshrining 
these procedures as obligations under TTIP would ensure that they are followed, and that 
there is increased consultation between the regulatory agencies. It would also give grounds 
for one party to complain if it had reason to believe that a regulatory agency on the other side 
did not undertake the required consultation steps. 
The regulatory cooperation section should also establish an institutional mechanism to oversee 
the regulatory cooperation process. This could be the existing US-EU High Level Regulatory 
Cooperation Forum (HLRCF)32 established in 2005, although it would make sense in the 
context of the increased requirements in TTIP to enhance it. President Obama’s Executive 
Order on international regulatory cooperation, mentioned above, recommended the 
establishment of regulatory cooperation councils (RCCs) with certain partners. The US 
                                                   
32 See www.whitehouse.gov/omb/oira_irc_europe  
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currently has RCCs with Canada33 and Mexico.34 These RCCs meet once or twice a year, 
bringing together select regulatory agencies to develop work plans for regulatory cooperation, 
report on progress to date, discuss best practices and other such steps. They have no law-
making capability as regulatory agencies on both sides must go through their domestic 
decision-making procedures to change any rules. This would be true as well for whatever 
oversight body TTIP creates. In addition to helping set the regulatory cooperation agenda and 
ensuring public reports, the oversight body would review experience, identify best practices 
among regulators, help resolve misunderstandings, expand and update the RCA and REA 
methodologies, and the like. 
In contrast to the HLRCF, which is fairly ad hoc in its participation, TTIP should identify the 
bodies which should participate. Ideally it would be co-chaired by the two bodies which 
oversee the regulatory activities of the two governments, the Office of Information and 
Regulatory Affairs (OIRA) of the US Office of Management and Budget (OMB), and the 
European Commission Secretariat General. All relevant agencies, including those dealing with 
risk assessment or regulation directly, should participate. 
The RCC name, while legally significant in the US context, has slightly different political 
connotations in the EU, where  ‘Councils’ are ministerial-level bodies that make law. This may 
be one reason why some in Europe distrust the idea. Another name should be chosen for the 
oversight body in TTIP to avoid this misperception. Indeed, the EU first draft on Regulatory 
Cooperation in TTIP speaks of a ‘body’.  
4.4 The Sectorial Annexes 
Structurally, one of the most important components of the regulatory cooperation part of TTIP 
is a set of sectorial annexes, for it is this structure which most clearly demonstrates that 
regulators are in the lead on regulatory cooperation, not trade negotiators. It is the former who 
are responsible for implementing the laws governing the level of safety of the products and 
services they regulate, and which are thus politically accountable to the relevant political 
oversight committees of Congress, the European Parliament and Council, and the national 
governments and parliaments. And it is this structure which clearly demonstrates to the 
legislative bodies, and to the public, that the desired levels of safety cannot be arbitrarily 
reduced (or increased) because of TTIP. 
Indeed, in both the US and EU, changes in the level of regulatory protection would 
undoubtedly require legislative or at least regulatory measures. In the US, any such change 
would be subject to the requirements of the Administrative Procedures Act, and thus subject 
to legal challenge, should the public notice and comment process not be followed. Similar 
requirements exist on the EU side. 
In this sense, TTIP can only occasionally be expected to bring about changes in underlying 
law; rather, it is a way to build bridges between two regulatory regimes. And bridges can only 
be built if the two sides are relatively close to one another. If the regulatory outcomes 
                                                   
33 See www.whitehouse.gov/omb/oira_irc_north_america#canada . See also OECD (2013b) for a report 
on how it works in actual practice.  
34 See www.whitehouse.gov/omb/oira_irc_north_america#mexico .  
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demanded by the two sides are far apart, then, at the very least, spans will need to be 
constructed to bring them closer together before anything further can be accomplished. 
The annexes should be kept simple, but should incentivise results in TTIP: each should have a 
heading reflecting the class of regulated products or services being referred to (autos, 
pharmaceuticals, medical devices, cosmetics, toys, apparel, banking, insurance, etc.); each 
should list the relevant regulatory agencies on both sides and perhaps points of contact in 
them; and each should reflect agreements that have been reached between the relevant 
regulators. One annex, for instance, could be on large civil aircraft: the Federal Aviation 
Administration and the European Aviation Safety Agency would be listed as the regulators, 
and the 2009 Bilateral Aviation Safety Agreement, mentioned above, should be linked on it.  
As this example highlights, the annexes should include existing agreements between 
counterpart US and EU regulators (such as on organic produce and supply chain security 
systems), any additional ones agreed during the TTIP negotiations, and any that may be 
agreed subsequent to agreement on TTIP. In other words, concrete results in regulator-to-
regulator exchanges should find their way into the annexes, so that they are anchored in TTIP, 
now or later.  
It is this last part, the ability to add new regulator-to-regulator agreements in the annexes, that 
makes the TTIP a ‘living’ agreement. As described previously, over the past decade and a half, 
many of our regulatory agencies have reached agreements with one another; they didn’t need 
TTIP to do this. But TTIP, with its horizontal obligations for such things as the RCA and the 
REA, will provide direction to that cooperation and ‘turbo-charge’ it, without undermining 
our respective regulatory processes.  
And this ‘living’ agreement both recognises that such regulator-to-regulator agreements can 
only come where regulators have trust and confidence in one another, and that such trust and 
confidence takes time to build. TTIP as a trade agreement should not and need not be delayed 
as that process unfolds. 
Annex 1 to this report provides an illustrative list of existing US-EU regulatory agreements in 
over 20 different sectors, on which these annexes should be built. 
5. Comparing regulatory cooperation chapters in three FTAs 
In order to get an idea of the ambition, nature, and level of intensity of bilateral regulatory 
cooperation between the US and of the EU so far, it might seem instructive to compare the 
regulatory chapters of recent bilateral trade agreements concluded by the parties. However, 
this is only partly true. Because no published information of any substantive detail is available 
about TPP (the Asia-Pacific FTA of 12 parties including the US),35 the only recent FTA 
concluded by the US is KORUS, the Korea-US FTA. The EU has concluded three recent FTAs, 
with Korea (KOREU in 2010), Singapore, and CETA. The latter two are still being legally 
scrubbed prior to signature and subsequent ratification. In the present section, some 
comparative remarks will be made about KOREU and SINGEU, on the one hand, and KORUS 
                                                   
35 From Schott, Kotschwar, and Muir (2013, p. 13), it appears that regulatory coherence texts focus on 
promoting transparency and streamlining standards, certification, and regulatory processes. In any 
event, the Honolulu APEC Ministerial was also the occasion for TPP to release a broad mandate, with 
regulatory coherence as one of the priorities. But no details are available beyond these generalities.  
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on the other. The relevant chapters in these three FTAs are all about transparency, only one 
aspect of regulatory coherence. What there is about regulatory cooperation is linked to sectors 
or may arise from general clauses for future initiatives of the ministerial-level body governing 
the FTA. No specific regulatory cooperation framework or chapter is included. This is different 
in CETA (see section 6).  
KOREU36 does not include a chapter entitled ‘Regulatory Cooperation’. Instead, chapter 12 is 
entitled ‘Transparency’. There is a possibility that this is caused by the simultaneity of the 
negotiations on KORUS and KOREU. It has often been suggested that KORUS served as a lead 
example for KOREU, and indeed the structure and substance of the two agreements are quite 
similar, and KORUS also has a chapter (21) called ‘Transparency’. The substance of chapter 12 
of KOREU goes some modest distance towards what one would expect from a chapter on 
horizontal regulatory cooperation, knowing that sectorial and other specific regulatory 
cooperation is also scattered throughout the treaty and annexes. Article 12.2 on objective and 
scope clarifies that “Recognising the impact which their respective regulatory environment 
may have on trade between them, the Parties shall pursue an efficient and predictable 
regulatory environment for operators, especially small ones doing business in their 
territories.” The chapter lays down clarifications and improved arrangements for 
transparency, consultations, and better administration of measures of general application. 
Subsequent articles re-iterate some of the OECD guidelines and recommendations referred to 
in BOX 3 – most EU Member States as well as Korea are members of the OECD – such as on 
timely publications, with the opportunity to comment and endeavours to take such comments 
into account before legislating for the measures. These are followed by provisions on 
mechanisms for enquiries and contact points, administrative proceedings, review and appeal, 
and cooperation in promoting regulatory quality. Chapter 14 of the provisional text of 
SINGEU37 on transparency is almost a copy of KOREU’s chapter 12. The objective, scope and 
structure is essentially the same, and often textually identical.  
KORUS chapter 21 is on transparency. For TTIP purposes, it looks rather elementary. 
Compared to chapter 12 of KOREU, it lacks a broader objective on an ‘efficient and predictable 
regulatory environment for operators,’ although one surmises that drafters must have had this 
in mind. Article 21.1 goes into great detail about several aspects of publication of laws, 
regulations, procedures and administrative rulings, such as timely publication in advance of 
proposals, providing a reasonable opportunity for stakeholders to comment, and a host of 
details ensuring easy access to information (e.g. a single official journal, a comment period of 
40 days, setting out the rationale, and addressing significant comments). Article 21.2 reiterates 
this for ‘requests’. Article 21.3 insists on administering ‘in a consistent, impartial and 
reasonable manner’, complemented with, again, reasonable notice and opportunity. 
Somewhat similar provisions apply (Art. 21.4) to review and appeal. Presumably because of 
occasional informal past campaigns in Korea against certain imported goods, Art. 21.5 seeks 
confirmation that that is not standing policy. A detailed anti-corruption and anti-bribery 
provision is found in Art. 21.6. In the light of recent APEC initiatives on regulatory reform and 
principles, largely overlapping with those of the OECD, one suspects that Chapter 21 of 
KORUS is more a reflection of the past (KORUS was negotiated up to 2007) than of today.  
                                                   
36 OJEU L 127 of 14 May 2011, pp. 6 - 1450 
37 See http://trade.ec.europa.eu/doclib/press/index.cfm?id=961  
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Whereas it is often suggested that KORUS is the template of how modern FTAs are negotiated 
by the US, this is clearly not true for the transparency chapter, and even less so for the US and 
the EU together, which have moved beyond the KORUS-type provisions in their regulatory 
cooperation during the last few decades. Nevertheless, for purposes of transparency for 
business in TTIP, one might go much further still. One example: wouldn’t it be a good idea to 
facilitate two-way business for SMEs, by creating a one-stop-shop on both sides, with easy 
access to regulatory requirements, both at the federal (or EU) and the sub-central (or member 
state) levels? Demanding surely for both partners, but undoubtedly extremely helpful for 
SMEs, lowering the costs - and perceived costs - of entry.  
6. TTIP’s regulatory cooperation: What CETA and the EU TTIP proposal 
tell us 
Regulatory cooperation is dealt with very differently in CETA. One important explanation for 
this difference in ambition is the existence of regulatory cooperation under the Canada-EU 
Framework on Regulatory Cooperation and Transparency, which dates back nearly a decade. 
Chapter 26 of the provisional consolidated text of CETA38 - which is about regulatory 
cooperation - states (in Art. 26.2 sub 5) that the chapter replaces the earlier framework, which 
implies an upgrade. Given the parallel histories of regulatory cooperation between the US and 
the EU and Canada and the EU, and the fact that Canada and the US have enjoyed a 
considerable degree of market integration in NAFTA for more than two decades, it is 
reasonable to regard CETA as a possible benchmark for a regulatory chapter in TTIP. 
However, it is not sure whether the TTIP negotiators see it that way; in any event, the US 
position on this chapter is as yet unknown. In Table 1 we compare the CETA chapter with the 
EU draft proposal on regulatory cooperation in TTIP.39 
Table 1. Comparing regulatory cooperation in CETA and the EU TTIP proposal 
CETA on Specifications in CETA Specifications in EU TTIP proposal 
Scope (Art 1) Development, review, and 
methodological aspects of regulatory 
measures of the Parties; reference to 
WTO SPS and TBT, plus GATT and 
GATS ; and to six chapters in the 
draft treaty, including environment 
and labour 
Art. 3: applies to regulatory acts at 
central level on goods and services; 
with ‘significant impact’; and 
regulatory acts concerning specific or 
sectorial provisions (to be 
determined later). The type of 
regulatory acts at central level are 
precisely defined in Art. 2, a and b 
for resp. the EU and the US] [note, 
that the first EU draft will be 
completed with provisions on 
regulatory acts at sub-central level 
][reference to WTO elsewhere in 
CETA] 
                                                   
38 See http://trade.ec. europa.eu/doclib/2014/september/tradoc_1528  
39 See http://trade.ec.europa.eu/doclib/docs/2015/february/trade_153120  




Quite detailed. Their cooperation is 
to be open to other trading parties; 
should ‘enhance the climate for 
competitiveness and innovation, 
including through pursuing 
regulatory compatibility, recognition 
of equivalence and convergence’; 
promote regulatory processes that .... 
better ... fulfil the mandates of 
regulatory bodies... [and] ‘enhanced 
use of best practices’ 
Art. 1.3 : ‘the Parties reaffirm their 
shared commitment to good 
regulatory principles and practices, 
as laid down in the OECD 
Recommendation of 22 March 2012 




Four very detailed objectives, i.e. 
contributing to SHIEC objectives (by 
leveraging international resources 
and helping risk assessment), 
building trust and deepening mutual 
understanding of regulatory 
governance (in seven ways, typical 
‘good regulatory practices’ items, 
including transparency and 
predictability), facilitating bilateral 
trade and investment (e.g. by 
reducing unnecessary regulatory 
differences), and contributing to 
competitiveness and efficiency of 
industry (by e.g. minimizing 
administrative costs and reducing 
duplicative regulatory requirements, 
plus pursuing compatible regulatory 
approaches e.g. recognition of 
equivalence or the promotion of 
convergence)  
Art.1.1 comprises four objectives:  
a. ‘to reinforce regulatory 
cooperation thereby facilitating trade 
and investment…. to stimulate 
growth and jobs while pursuing a 
high level of protection..’ in SHEIC 
but also working conditions, 
personal data, cybersecurity, cultural 
diversity or preserving financial 
stability; 
b. ‘reduce unnecessarily 
burdensome, duplicative or 
divergent regulatory 
requirements…. by promoting … 
compatibility of… EU and US… acts’ 
c. ‘promote an effective, pro-
competitive environment… 
transparent and predictable ‘ 
d. ‘to further… international 
instruments … to strive towards 





A very wide and ambitious set of 
provisions on 19 (!) regulatory 
cooperation activities, many of those 
on sharing /exchange of information 
on a host of areas, examining 
opportunities to minimise 
unnecessary divergences, 
cooperation on developing 
international standards and guides, 
data collection, cooperative research 
agendas, conducting post-
implementation reviews, reducing 
adverse trade effects by, e.g., greater 
convergence, mutual recognition, 
minimising the use of trade-
distorting instruments, and the use 
of international standards, etc.  
In the draft EU proposal, many (not 
all) regulatory cooperation activities, 
as they are called in CETA, are found 
in different articles .  
Art. 5 (on early and public 
information on planned acts) and 
Art. 6 (on stakeholder consultations) 
are under a subsection 
‘transparency’, whereas the first 
(early information) is in Art. 26.4 of 
CETA, that is not the case for 
stakeholder participation (except for 
a very open clause in Art 26.8, 
CETA). 
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Provisions on impact assessment (in 
CETA Art. 26.4, item 6b) are in Art. 7 
in the EU proposal. 
Some of what CETA calls ‘activities’ 
are the subject of ‘regulatory 
exchanges’ in the EU proposal (art. 9 
and 10), the essential difference 
being a greater precision in 
procedures and timing. 
(For the CETA provision on post-
implementation reviews, there is a 
weak counterpart in the EU draft, in 
Art. 7.3c) On the other hand, CETA 
has no explicit provision on 
promoting international regulatory 





‘With a view to enhancing 
convergence and compatibility 
between regulatory measures of the 
Parties, each Party shall, when 
appropriate, consider the regulatory 
measures or initiatives of the other 
Party on the same or related 
topics…’ 
Compatibility is in Art. 8.1 as well as 
in Art. 11, following from (in some 
cases) so-called ‘regulatory 
exchanges’, specifying mutual 
recognition of equivalence (of 
regulatory acts or outcomes), 
harmonization or simplification; goes 






Forum (Art. 6) 
‘...to facilitate and promote 
regulatory cooperation between the 
Parties’; functions: (i) a setting for 
discussion of regulatory policy issues 
of mutual interest, (ii) assist 
individual regulators (identifying 
partners; model confidentiality 
agreements); (iii) reviews of whether 
regulatory initiatives ‘provide 
potential for cooperation’; (iv) 
encourage bilateral regulatory 
cooperation activities (as the 19 types 
in Art. 4) and review sectorial 
initiatives. The RCF reports to the 
CETA trade Council 
The TTIP Regulatory Cooperation 
Body will have seven functions (art. 
14): i. Annual Regulatory 
Cooperation Programme; ii. 
monitoring of the implementation 
and reporting; iii. technical 
preparation of new or added sectoral 
provisions; iv. considering new 
proposals for regulatory cooperation, 
including on compatibility; v. 
preparation of joint proposals of 
international regulatory instruments; 
vi. ensuring transparency; vii. open 
clause on relevant ‘other issue’ 
Further 
cooperation of 
the Parties (Art. 
7)  
Is about monitoring forthcoming 
regulatory projects, as well as 
exchange of information on a host of 
issues, e.g. standardisation, market 
surveillance, risk assessment 
methods and product recalls and 
early warnings. Endorsement of 
other initiatives are encouraged too.  
Not explicit but probably subsumed 
in Art. 14; presumably, market 
surveillance, risk assessment and 
product recalls may require more 
specific provisions 
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Consultations 
(Art. 8)  
‘in order to gain non-governmental 
perspectives, the Parties may jointly 
or separately consult’ all kinds of 
private entities 
Much more detailed and 
forthcoming or encouraging on 




Specified for both Parties Not (yet ? ) specified 
 
Table 1 shows that CETA and – probably – TTIP are going to be very different from recent 
FTAs in terms of regulatory coherence and cooperation. Although there are differences 
between the two texts, and some confusing disparities in structure, the overlap in the 
substantial provisions about regulatory cooperation and coherence is quite large. Both also 
envisage a joint body with a fairly wide and flexible remit which enables future cooperation 
in many ways. It would also facilitate the idea and operation of a ‘living agreement’. In the 
regulatory coherence part, the reference to the OECD 2012 recommendations (in the EU 
proposal) re-affirms a common set of principles and practices in an explicit and well-codified 
form which effectively overlaps with what CETA Articles 2 and 3 contain. In the EU TTIP text 
the ‘regulatory exchanges’ are to be led by the regulators (art. 9.4); this is not explicit in CETA. 
On the other hand, one would surmise, at this stage, that the TTIP approach as proposed by 
the EU is more ambitious in terms of commitments and procedures than CETA, as the hard 
core of the CETA chapter are (19) voluntary cooperative ‘activities’ whereas TTIP regulatory 
cooperation is far more about commitments in law. Still, much will depend on the actual 
functioning of the chapter under each treaty. In any event, TTIP already has (tentatively) 
agreed on as many as nine sectorial chapters or annexes, and the EU proposal suggests that 
more might eventually emerge from the ‘living agreement’, whereas in CETA it does not look 
nearly as ambitious when taking the text literally.  
Of course, the EU text is still incomplete with respect to sub-central governments. Neither 
CETA nor the EU texts are very detailed with respect to some ‘coherence’ aspects discussed in 
our section 4 above. For example, there is not much detail on early information of planned 
drafts for the other party or the public at large. With respect to the horizontal aspects of 
cooperation, nothing even nearly as ambitious as Regulatory Compatibility Assessments for 
new regulations and/or Regulatory Equivalence Assessment for existing regulations is 
referred to in either text.  
In the absence of a publicised US text proposal or a revision after nine rounds of negotiation, 
it would be wrong to draw any further conclusion at this stage.  
7. Conclusion: Building bridges and enhancing social objectives 
The purpose of the Transatlantic Trade and Investment Partnership is to build on the unique 
trade and investment-based US-EU economic relationship to promote growth and, most 
importantly, jobs on both sides of the Atlantic.  
It will do this in many ways, but one of the key steps will be in tackling unnecessary differences 
in regulation, which create unintended obstacles to trade without any corresponding 
regulatory or social benefit. The US and EU can do this, as they are both democratic, high-
income economies that in general seek similar levels of consumer, worker, environmental and 
prudential safety.  
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But TTIP can succeed only if it frames this process correctly. TTIP will not be, and perhaps 
cannot be, the most ambitious form of regulatory cooperation, as seen in some treaties focused 
on discrete issues. But it can, and probably will, be more than either side has done in any 
previous trade agreement. Done properly, regulatory coherence and cooperation under TTIP 
will enhance regulatory efficiency and effectiveness, increasing consumer safety even as it 
improves the competitiveness of US and EU firms. TTIP should help ensure that regulators on 
both sides of the Atlantic agree on the principles and practices that make for a robust, 
evidence-based and transparent regulatory system, as confidence in each other’s domestic 
systems is a prerequisite for cooperation. It should set the clear goal for our regulators of 
improving regulatory compatibility, while reaffirming their autonomy and their 
accountability to their political oversight bodies and their citizens. It should give them tools 
such as the Regulatory Compatibility Assessments and the Regulatory Equivalence 
Assessments, to ensure informed decision-making without trying to predetermine the 
outcomes. And it should recognise that regulatory cooperation can succeed only where there 
is trust and confidence between the regulators, and that TTIP must be patient enough and 
flexible enough with a living agreement, to allow for this trust and confidence to be built on 
sufficiently strong foundations. 
For only with these foundations will TTIP be able to build a bridge between the US and the 
EU, one that is safe, that meets the needs and concerns of our politicians and our citizens, while 
at the same time fostering economic growth and job creation. 
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Annex 1. 20 Years of US-EU Regulatory Cooperation 
Regulators in the United States and European Union (as opposed to individual EU member 
states) have been collaborating since the 1995 US-EU “New Transatlantic Agenda” 
declaration. While there are a number of agency-to-agency agreements, much of the early 
work was captured in the general reports on progress under the Regulatory Cooperation 
Roadmaps (starting in 2002), to the High Level Regulatory Cooperation Forum (established 
2005) and ultimately the Transatlantic Economic Council (TEC), created in 2007. A review of 
these general reports, listed in the first section below, gives a good overview of progress in 




US-EU Joint Statement on Regulatory Cooperation (Dec. 1997) 
US-EU MRA Agreement (December, 1998) 
Guidelines for use of the MRAs, 2001 
Transatlantic Economic Partnership Report (Bonn Summit, June 1999) 
Transatlantic Economic Partnership; Commission  Overview and 
Assessment, October 2000 
Guidelines on Regulatory Cooperation and Transparency 
Implementation Roadmap (April 2002) 
Regulatory Roadmap – 2004 
Regulatory Roadmap – June 2005 
Joint Report on the Roadmap, June 2006 
Joint Report on the Roadmap, April 2007 
HLRCF Report, April 2008 
Joint Report on Impact Assessments and Trade, May 2008 
HLRCF Report, October 2008 
HLRCF Report, July 2009 
HLRCF Report, June 2010 
HLRCF Report, December 2010 
Common Understanding re Regulatory Principles and Best Practices, 
June 2011 
Standards 
US: National Institute of 
Standards and 
Technology (NIST) 
EU: DG Enterprise 
(GROW); Joint Research 
Centers 
EU and US Extend Scientific Cooperation on Measurements and 
Standards July 2013 (JRC news release) 
Building Bridges Between the U.S. and EU Standards Systems Nov 2011 
Memorandum of Understanding Dec 2010 
U.S. – EU HLRCF Joint Statement on Standards in Regulation Dec 2010 
Collaborative Arrangement  regarding cooperation in the fields of 
metrology and measurement standards Feb 2008 
Memorandum of Understanding regarding cooperation on scientific 
research and measurement standards Dec 2007 
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Import Product Safety 
US: OIRA 
EU: DG Enterprise 
Implementation of Recommendations Report, December 2008 
Safety of Imported Products, April 2008: looks at motor vehicle, food, 




US: FDA, USDA, FSIS, 
APHIS 
EU: DG SANCO/SANTE, 
DG AGRI 
National Organic Program June 2012: the U.S. and EU created an 
equivalence arrangement in regards to organic standards USDA press 
release   
Competent authorities responses of the US to recommendations from 
DG SANCO 2011 
FCA and EFSA information sharing agreement July 2007: the two 
agencies signed the first EU – U.S. agreement in the area of assessing 
food safety risk. EFSA Statement  FDA Statement  
EU-US Safe Food 2005-2007: A program that ran for two years in order 
to contribute to and communicate knowledge about food born 
zoonoses. 
Report, 2007: complete Implementation Plan under their confidentiality 
arrangement; experts hold joint meeting on nanotechnology in food to 
share perspectives on the issue. 
Chemicals: 
US: EPA 
EU: DG ENVI, ENT; 
ECHA 
ECHA and EPA statement of Intent  Dec 2010: The document asserts the 
agencies intent to enhance technical cooperation and share information 
regarding chemical management. EPA press release 
US-EU Conference Draft Nanotechnology in the Workplace July 2012: 
Establishing standardization OSH principles for developing best 




EU: DG ENT, EMEA 
 
EC wavier for export of U.S. pharmaceutical manufactures  June 2013  
Update on the implementation of recommendations made by 
Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) Feb 2013 
Programme to rationalize international GMP inspections Feb 2012 
Enhancing GMP Inspection Cooperation between EMA and FDA Dec 
2011 
Report on the Pilot EMA-FDA GCP Initiative July 2011:  
Implementation Report on Transatlantic Administration Simplification 
action plan July 2011 
Interactions between EMA and FDA June 2011 
Report on the International API inspection Pilot May 2011 
EMA-FDA pilot program for parallel assessment of Quality by design 
applications March 2011 
Transatlantic Taskforce on Antimicrobial Resistance Report 2011:  
EMEA and FDA statements re non-disclosure of confidential information 
from partner agency (September 2010)  
FDA EMEA Administrative Simplification Implementation Report Oct 
2009 
EMEA-FDA Good Clinical Practice (GCP) Initiative Terms of engagement 
and procedures for participating authorities: Sep 2009 
EMEA-FDA GCP Initiative July 2009 
EMEA-DFA Parallel Scientific Advice July 2009 
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Confidentiality Commitment between the FDA and EDQM May 2009 
Update on pilot project to collaborate on international GMP inspection 
activities Jan 2009 
FDA/EMEA Joint Press Release re Cooperation on Medicines, Oct 2008 
Medicines Regulation: Transatlantic Administrative Simplification Action 
Plan June  2008 
Veterinary Medicines 
US: FDA, USDA 
EU: EC, EMEA 
 
(See also above re medicines and reports on TATFAR) 
CVM / EMA Exchange of Experts 2012  
FDA EDQM Confidentiality Commitment May 2009: 
EMEA / Veterinary Medicines and Inspections Unit – Parallel Scientific 
Advice Meetings May 2008 




EU: DG ENTR – EMEA  
October 2012 EU proposed changes to Medical Device laws and allowed 
U.S. comments  
Statement From the International Medical Device Regulators’ Forum 
October 2011 
Exchange of Letters to facilitate information sharing re the safety, 








ICCR (International Cooperation on Cosmetic Regulation): made up of 
the US, EU, Japan, and Canada  
Meeting reports: 2012, 2011, 2010, 2009, 2008, 2007  
FDA – DG Enterprise – Related to Cosmetics July 2007: Press Release 
Automotive Safety 
US: NHTSA 
EU: DG ENT 
Europe, USA, Japan will harmonize electric Vehicle Regulations Nov 
2011 
Proposal for two working groups re e-Vehicles Nov 2011 
Global Technical Regulations 2004-2011 
Memorandum of Cooperation Automobiles June 2008  (PDF) 
Aircraft Safety: 
US: FAA, TSA 
EU: DG ENT, EASA 
Cooperation Agreement on Civil Aviation Safety March 2011 




EU DG Energy and 
Transport; European 
Marine Safety Agency  
 
 
Memorandum of Understanding regarding marine optical radiometry 
March 2011:  
US-EC Marine Equipment MRA Joint Committee Feb 2009:  
US-EU Mutual Recognition Agreement for Conformity Assessment for 
Marine Equipment, June 2001 
Energy Efficiency, Eco-
Design 
US: DOE, FERC, EPA 




EU – US Energy Council Press statements following meetings of the 
Council  
o December 2012 
o November 2011 
o November 2010 
o Website on the council is here  
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EU US Energy Council Working Group on Technology, Research, 
Development and Demonstration 2009 
Establishment of EU-US Energy Council, 2009  
EU U.S advance Energy dialogue March 2008 :  
Energy Star Agreement renewed Jan 2013  
Implementing Arrangement for Environmental Research and 
Ecoinformatics, Feb 2007:  
Energy star agreement, December 2001 Working link First Energy Star 




EU DG SANCO 
 
China – U.S. – EU trilateral meetings 
o Sep 2008 Joint Press Statement 
o October 2010 Joint Press Statement 
o June 2012 Joint Press Statement  
Roadmap Feb 2010:  
Council grants mandate for the EC Nov 2009:  
EU US HLRCF Report on the Safety of Imported Products Dec 2008:  
EU US HLRCF Report on Safety of Imported Products May 2008 
Report, 2007:  
Guidelines for Information Exchange and on Administrative Cooperation 
on consumer product safety1, Report, 2006 
 
Toy Safety Jan 2010:  
Financial 
Regulation/Supervision 
US; Treasury, Federal 
Reserve, SEC, CFTC, 
NAIC, FASB, PA 




Derivatives Agreement, July 2013 (Press release and text from CFTC) 
SEC and CESR Announcement Nov 2010:  
The SEC abolished reconciliation to GAAP for foreign companies using 
IFRS Nov 2007 
CESR and SEC Protocol to implement work plan Sept 2007 
SEC and CESR Work Plan Aug 2006 
 
Insurance  
U.S. EU Dialogue Project Update, April 2013 
EU – U.S. Dialogue Project Report Dec 2012 
EU – U.S. Dialogue Project: The Way Forward Dec 2012 
Transportation 
Security 
US : DHS / CBP and TSA, 
FAA, FMC 
EU: DG JHA 
 
CBP, EU Sign C-TPAT Mutual Recognition Decision May 2012 (Implement 
this report Feb 2013)  
Air Cargo Agreement June 2012. TSA press release, EU press release 
U.S. – EU Joint Declaration on Aviation Security January 2010 :  
Joint Statement September 2008   
Agreement Between the United States of America and the European 
Union On The Use and Transfer of Passenger Name Records to the 
United States Department of Homeland Security, December 2011  
Agreement re Passenger name Records, July 2007  
Trusted Trader Program May 2012 







Founded in Brussels in 1983, the Centre for European Policy Studies (CEPS) is widely recognised as 
the most experienced and authoritative think tank operating in the European Union today. CEPS 
acts as a leading forum for debate on EU affairs, distinguished by its strong in-house research 
capacity, complemented by an extensive network of partner institutes throughout the world. 
Goals 
• Carry out state-of-the-art policy research leading to innovative solutions to the challenges 
facing Europe today, 
• Maintain the highest standards of academic excellence and unqualified independence  
• Act as a forum for discussion among all stakeholders in the European policy process, and 
• Provide a regular flow of authoritative publications offering policy analysis and 
recommendations, 
Assets 
• Multidisciplinary, multinational & multicultural research team of knowledgeable analysts, 
• Participation in several research networks, comprising other highly reputable research 
institutes from throughout Europe, to complement and consolidate CEPS’ research expertise 
and to extend its outreach,  
• An extensive membership base of some 132 Corporate Members and 118 Institutional 
Members, which provide expertise and practical experience and act as a sounding board for 
the feasibility of CEPS policy proposals. 
Programme Structure 
In-house Research Programmes 
Economic and Social Welfare Policies 
Financial Institutions and Markets 
Energy and Climate Change 
EU Foreign, Security and Neighbourhood Policy 
Justice and Home Affairs 
Politics and Institutions 
Regulatory Affairs 
Agricultural and Rural Policy 
Independent Research Institutes managed by CEPS 
European Capital Markets Institute (ECMI) 
European Credit Research Institute (ECRI) 
Research Networks organised by CEPS 
European Climate Platform (ECP) 
European Network for Better Regulation (ENBR) 
European Network of Economic Policy 
Research Institutes (ENEPRI) 
European Policy Institutes Network (EPIN) 
 
